These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23219306)

  • 21. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.
    Wüllner U; Reimold M; Abele M; Bürk K; Minnerop M; Dohmen BM; Machulla HJ; Bares R; Klockgether T
    Arch Neurol; 2005 Aug; 62(8):1280-5. PubMed ID: 16087769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical excitability in juvenile myoclonic epileptic patients and their asymptomatic siblings: a transcranial magnetic stimulation study.
    Akgun Y; Soysal A; Atakli D; Yuksel B; Dayan C; Arpaci B
    Seizure; 2009 Jul; 18(6):387-91. PubMed ID: 19297206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central motor conduction to lower limb after transcranial magnetic stimulation in spinocerebellar ataxia type 2 (SCA2).
    Restivo DA; Giuffrida S; Rapisarda G; Antonuzzo A; Saponara R; Reggio A; Trovato Salinaro A; Raffaele R; Domina E; Trovato A; Condorelli DF; Pennisi G
    Clin Neurophysiol; 2000 Apr; 111(4):630-5. PubMed ID: 10727914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
    Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
    J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
    Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
    Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequencies of spinocerebellar ataxia subtypes in Thailand: window to the population history?
    Sura T; Eu-Ahsunthornwattana J; Youngcharoen S; Busabaratana M; Dejsuphong D; Trachoo O; Theerasasawat S; Tunteeratum A; Noparutchanodom C; Tunlayadechanont S
    J Hum Genet; 2009 May; 54(5):284-8. PubMed ID: 19329990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The electrophysiology of spinocerebellar ataxias.
    Liang L; Chen T; Wu Y
    Neurophysiol Clin; 2016 Feb; 46(1):27-34. PubMed ID: 26947625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CAG trinucleotide mutation detection in patients with hereditary spinocerebellar ataxia].
    Tang B; Xia J; Wang D; Tang X; Shen L; Liu C; Dai H; Yan X; Pan Q; Xiao J; Zhang B; Ou Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):281-4. PubMed ID: 10514531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Copy number variation of trinucleotide repeat in dynamic mutation sites of autosomal dominant cerebellar ataxias related genes].
    Chen P; Ma M; Shang H; Su D; Zhang S; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Dec; 26(6):626-33. PubMed ID: 19953483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consistent affection of the central somatosensory system in spinocerebellar ataxia type 2 and type 3 and its significance for clinical symptoms and rehabilitative therapy.
    Rüb U; Seidel K; Ozerden I; Gierga K; Brunt ER; Schöls L; de Vos RA; den Dunnen W; Schultz C; Auburger G; Deller T
    Brain Res Rev; 2007 Feb; 53(2):235-49. PubMed ID: 17014911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of cortical excitability of human motor cortex in spinocerebellar ataxia type 2. A study with paired transcranial magnetic stimulation.
    Restivo DA; Lanza S; Saponara R; Rapisarda G; Giuffrida S; Palmeri A
    J Neurol Sci; 2002 Jun; 198(1-2):87-92. PubMed ID: 12039668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural history of central motor abnormalities in amyotrophic lateral sclerosis.
    Mills KR
    Brain; 2003 Nov; 126(Pt 11):2558-66. PubMed ID: 12937082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6.
    Linnemann C; Tezenas du Montcel S; Rakowicz M; Schmitz-Hübsch T; Szymanski S; Berciano J; van de Warrenburg BP; Pedersen K; Depondt C; Rola R; Klockgether T; García A; Mutlu G; Schöls L
    Cerebellum; 2016 Apr; 15(2):165-73. PubMed ID: 26054379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central auditory processing in patients with spinocerebellar ataxia.
    Zeigelboim BS; de Carvalho HA; Teive HA; Liberalesso PB; Jurkiewicz AL; da Silva Abdulmassih EM; Marques JM; Cordeiro ML
    Hear Res; 2015 Sep; 327():235-44. PubMed ID: 26183435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
    Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
    Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?
    Schöls L; Amoiridis G; Büttner T; Przuntek H; Epplen JT; Riess O
    Ann Neurol; 1997 Dec; 42(6):924-32. PubMed ID: 9403486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor cortical dysfunction develops in spinocerebellar ataxia type 3.
    Farrar MA; Vucic S; Nicholson G; Kiernan MC
    Clin Neurophysiol; 2016 Nov; 127(11):3418-3424. PubMed ID: 27689815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.